Robert J Brilon - 23 Sep 2021 Form 4 Insider Report for Iveda Solutions, Inc. (IVDA)

Role
Chief Financial Officer
Signature
/s/ Robert J. Brilon
Issuer symbol
IVDA
Transactions as of
23 Sep 2021
Net transactions value
+$210,696
Form type
4
Filing time
27 Sep 2021, 06:47:32 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IVDA Common Stock Options Exercise $44,800 +320,000 $0.1400* 320,000 07 Dec 2020 Direct F1
transaction IVDA Common Stock Options Exercise $165,896 +473,988 $0.3500* 473,988 30 Jun 2017 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVDA Options (Right to Buy) Award $0 +100,000 $0.000000 100,000 29 Dec 2017 Common Stock 100,000 $0.1000 Direct F3
transaction IVDA Options (Right to Buy) Award $0 +100,000 $0.000000 100,000 28 Dec 2018 Common Stock 100,000 $0.0400 Direct F3
transaction IVDA Options (Right to Buy) Award $0 +20,000 $0.000000 20,000 20 Dec 2019 Common Stock 20,000 $0.2800 Direct F3
transaction IVDA Options (Right to Buy) Options Exercise $0 -100,000 -100% $0.000000* 0 07 Dec 2020 Common Stock 100,000 $0.1400 Direct
transaction IVDA Options (Right to Buy) Options Exercise $0 -100,000 -100% $0.000000* 0 07 Dec 2020 Common Stock 100,000 $0.1400 Direct
transaction IVDA Options (Right to Buy) Options Exercise $0 -100,000 -100% $0.000000* 0 07 Dec 2020 Common Stock 100,000 $0.1400 Direct
transaction IVDA Options (Right to Buy) Options Exercise $0 -20,000 -100% $0.000000* 0 07 Dec 2020 Common Stock 20,000 $0.1400 Direct
transaction IVDA Options (Right to Buy) Award $0 +200,000 $0.000000 200,000 15 Dec 2020 Common Stock 200,000 $0.3700 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common stock was acquired from exercise of options.
F2 Common stock was acquired from conversion of Series A Preferred Shares
F3 The options subject to these grants vested 100% on the date of the grant.